Ondansetron oral solution is indicated for the prevention of nausea and vomiting associated with:
• highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2
• initial and repeat courses of moderately emetogenic cancer chemotherapy
• radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen
Ondansetron oral solution is also indicated for the prevention of postoperative nausea and/or vomiting.
